We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Deciwatt develops renewable energy solutions and its new product (nowlight), creates instant power and light from the pull of a cord. This company created 'nowlight' leveraging on the success of its first product ‘GravityLight’, which had secured media coverage from around the world, won many awards and was sold by major retailers like Best Buy and Walmart. Additionally, it has been awarded a new £173,788 grant from Innovate UK to integrate Pay-As-You-Go technology into nowlight. Further, this company has a pending registered trademark on the nowlight name and a patent pending on the manual power generation mechanism. It will invest the fund raised in implementing its marketing plans, further product development, and scale up its marketing activity and develop its business.
days to go: Expired investment: £519,607
Founded in 2017, Urban Electric aimed to create the world's largest urban electric vehicle charging networks. The company has now introduced the UEone 'pop-up' charge point. The company is working with Oxford, Plymouth City councils, & MoUs with Dundee. Since summer 2018, Urban Electric secured 'Innovate UK' project that backed £600K to install the world's initial 'pop-up' charging hub in partnership with Oxford City. With the proceeds, the company will be able to deliver a great customer experience, manage the grid, and allow drivers to make money from the excess energy stored in the car battery. In 2020, the company is aiming to install 18 additional charging hubs in Plymouth and Dundee.
days to go: Expired investment: £480,130
Nourish by Jane Clarke (NBJC) is an aspirational wellness brand that makes nutritious drinks made with all-natural organic ingredients, using low carbon footprint packaging, delivered to a customer's doorstep. Its target audience is people afflicted with malnutrition particularly when undergoing cancer treatment or living with dementia or mental illness. The company expanded its customer base by 789% between January 2020 and March 2021. It also points out that it has onboarded noted Chef Prue Leith. The company has featured in numerous publications like Daily Mail, Net Doctor, The Sun Online, and Daily Express, to name a few. NBJC has raised more than £650,000 from private investors in its previous round and secured an 'Excellent' rating of 4.7 on Trustpilot from 100+ verified reviews. It also seeks to become a contender in the Oral Nutritional Supplement (ONS) market in the UK that is valued at £237 million. The company will use the investment to launch and scale its B2B model and invest in Direct-to-Consumer (DTC) marketing.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £257,579
NGX is a nutrition company that claims to have made the world’s first genetically personalised nutrition-shake, backed by nutritionists and scientists. The company is in the process of filing a patent for its product. It asserts that recommended food guidelines are based on population averages that are generic and not suitable for achieving optimum physical, mental fitness and health. NGX claims that its customer-specific products are trustworthy as they are made based on a DNA Nutrition Test (DNT) that is unique to a person. The company is operating in the $87 billion fitness market and aims to be a major contender. NGX has sold 30,000 NGX meals since its launch in 2020, collected data on over 5,000 genetic variations, and created proprietary gene-nutrition matching algorithms. It was a finalist in the 2019 British Business Awards (Health & Wellness) and has featured in publications like Glamour, Men's/Women's Health amongst others. The company will use the investment to support customer acquisition activities, team expansion, product supply, and brand partnerships deals.
days to go: Expired investment: £294,934
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.

Pitch Rated

44%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £908,950
Aardvark is a company that manufactures dry kibbles for dogs and cats using insects as the source of protein. It has partnered with VC backed insect farm NextProtein. The company claims that its products meet the nutritional needs of pets while creating a smaller environmental footprint than pet food that uses animal meat. It also asserts that insect protein is endorsed by the British Veterinary Association. The company has developed its kibbles to be grain-free, consist of seaweed and other natural ingredients with no fillers. The UK pet food market is poised to grow to £2.9 billion in 2020, and the company aims to be a sustainable manufacturer in this segment.  The company requires investment to assist in manufacturing its first batch of pet food, help market its products to pet owners across the UK, and expand into Europe by 2021 and the U.S by 2024.
days to go: Expired investment: £300,290
A rapidly growing printing, merchandising and clothing brand with customers including Google, Amazon and Nike. Awesome Merchandise produce all their products in-house and ship internationally. The company has created over 65 million items for more than 70,000 customers and have been in profit every year. Investment will help to build a new factory based in Austin, TX, USA and to create US and European websites.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £654,870
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £144,265
East London Liquor Company (ELLC) has been distilling, importing and serving gins, whiskies, vodkas, rums, and canned cocktails since 2014. ELLC asserts that off-trade gin sales hit US$8.4 billion in 2020 with UK seltzer sales expected to reach £75 million by 2023. It intends to become a contender in the aforementioned categories. ELLC has had a 600% Year-on-Year (YoY) increase to £206,000 in off-trade sales from 2019-2020 to 2020-2021. The company has partnered with the UNESCO world heritage site, Royal Botanic Gardens, Kew, to release its product, Kew Gin. It has also entered into the Ready-To-Drink and seltzer categories with its range of canned drinks, and onboarded retailers like Waitrose, Tesco, and Co-Op. The company will use the investment to grow its off-trade channels both in the UK and abroad, expand its Direct To Consumer (DTC) output, update its 'Brand Home' to attract more customers, and increase its whisky production to meet demand.
days to go: Expired investment: £921,686
Gendius' has created intellin, an application through which people can track diabetes and make a good decision to reduce the risk of diabetes. It is on a mission to make sure that every person with diabetes knows their risk of complications and how to control them. The company has been launched across the EU with over 3,500 downloads in the EU and UK. In 2018, the company won £25K Momentum award to complete UX/UI research and, it has passed ISO27001. Recently, it has been invited to HIMSSHealth2.0 conference for the application's live demo.
days to go: Expired investment: £518,630
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph